Paula Rodriguez Otero (P Rodriguez-Otero, Paula Rodriguez-Otero, Paula Rodríguez-Otero, Paula Rodríguez Otero)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 37

Top Topics

Circulating Tumor

Multiple Myeloma

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Iñaki Ortiz de Landazuri, Aina Oliver-Caldés, Marta Español-Rego, Cristina Agulló, María Teresa Contreras, Aintzane Zabaleta, Noemí Puig, Valentín Cabañas, Verónica González-Calle, Inés Zugasti, Susana Inogés, Paula Rodriguez Otero, Beatriz Martin-Antonio, Juan Luis Reguera, Ascensión López-Diaz de Cerio, Juan Ignacio Aróstegui, Mireia Uribe-Herranz, Daniel Benítez-Ribas, Luis Gerardo Rodríguez-Lobato, Europa Azucena González, Natalia Tovar, Paola Charry, Sergio Navarro, Laura Rosinol, Karen Tréboles, Génesis Mora, Jordi Yagüe, José María Moraleda, Álvaro Urbano-Ispizua, Maria-Victoria Mateos-Manteca, Mariona Pascal, Bruno Paiva, Manel Juan, Carlos Fernández de Larrea
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells. British journal of haematology (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Michael H Tomasson, Shinsuke Iida, Ruben Niesvizky, Mohamad Mohty, Nizar J Bahlis, Joaquin Martinez-Lopez, Guenther Koehne, Paula Rodriguez Otero, H Miles Prince, Andrea Viqueira, Eric Leip, Umberto Conte, Sharon T Sullivan, Alexander M Lesokhin
Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study. HemaSphere 8 (7) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Marta Garrote, Marta Español-Rego, Aintzane Zabaleta, Verónica González De La Calle, Sergio Navarro-Velázquez, Susana I Inoges, Ascensión López-Díaz de Cerio, Valentín Cabañas, Nieves López-Muñoz, Paula Rodriguez Otero, Juan Luis Reguera, David F Moreno, Nuria Martinez-Cibrian, Lucía López Corral, Lorena Perez-Amill, Beatriz Martin-Antonio, Laura Rosinol, Joan Cid, Natalia Tovar, Joaquin Saez-Peñataro, Miriam Lopez-Parra, Eulalia Olesti, Elena Guillen, Sara Varea, Luis-Gerardo Rodríguez-Lobato, Anthony Matthew Battram, Marta Sonia González, Andrés Sánchez-Salinas, Europa Azucena González-Navarro, Valentín Ortiz-Maldonado, Julio Delgado, Felipe Prosper, Manel Juan, Joaquin Martinez Lopez, José María M Moraleda, Maria-Victoria Mateos-Manteca, Alvaro Urbano-Ispizua, Juan José Lahuerta, Mariona Pascal, Carlos Fernández de Larrea
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
Sikander Ailawadhi, Bertrand Arnulf, Krina K Patel, Michele Cavo, Ajay K Nooka, Salomon Manier, Natalie S Callander, Luciano José Megale Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R Solomon, Ingerid Weum Abrahamsen, Rachid C Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesus G Berdeja, Sergio A Giralt, Anna Truppel-Hartmann, Yanping Chen, Xiaobo Zhong, Fan Wu, Julia Piasecki, Laurie Eliason, Devender S Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa-Mckiver, Paula Rodriguez Otero
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses. Blood (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Marta Garrote, Marta Español-Rego, Aintzane Zabaleta, Verónica González De La Calle, Sergio Navarro-Velázquez, Susana I Inoges, Ascensión López-Díaz de Cerio, Valentín Cabañas, Nieves López-Muñoz, Paula Rodriguez Otero, Juan Luis Reguera, David F Moreno, Nuria Martinez-Cibrian, Lucía López Corral, Lorena Perez-Amill, Beatriz Martin-Antonio, Laura Rosinol, Joan Cid, Natalia Tovar, Joaquin Saez-Peñataro, Miriam Lopez-Parra, Eulalia Olesti, Elena Guillen, Sara Varea, Luis-Gerardo Rodríguez-Lobato, Anthony Matthew Battram, Marta Sonia González, Andrés Sánchez-Salinas, Europa Azucena González-Navarro, Valentín Ortiz-Maldonado, Julio Delgado, Felipe Prosper, Manel Juan, Joaquin Martinez Lopez, José María M Moraleda, Maria-Victoria Mateos-Manteca, Alvaro Urbano-Ispizua, Juan José Lahuerta, Mariona Pascal, Carlos Fernández de Larrea
Biomarkers of efficacy and safety of the academic BCMA-CART ARI0002h for the treatment of refractory multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Maria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, Maria Eréndira Calleja-Cervantes, Nerea Berastegui, Aintzane Zabaleta, Leire Burgos, Diego Alignani, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Susana I Inoges, Ascensión López-Diaz-de-Cerio, Sofia Huerga, Luis Esteban Tamariz-Amador, Jose J Rifon, Ana Alfonso, Juan Jose Lasarte, Juan José Lahuerta, Mikel Hernaez, Paula Rodriguez Otero, Jesús San F Miguel, Teresa Ezponda, Juan Roberto Rodriguez-Madoz, Felipe Prosper
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma. Blood advances (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
Aintzane Zabaleta, Laura Blanco, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Marta Lasa, Luis Esteban Tamariz-Amador, Paula Rodriguez Otero, Jesús San F Miguel, Bruno Paiva, Esperanza Martin-Sanchez
A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies. British journal of haematology (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Esperanza Martin-Sanchez, Luis Esteban Tamariz-Amador, Camilla Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesús San F Miguel, Paula Rodriguez Otero, Juan José Lahuerta, null null
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19. Blood cancer journal 14 (1) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Michael H Tomasson, Shinsuke Iida, Ruben Niesvizky, Mohamad Mohty, Nizar J Bahlis, Joaquin Martinez-Lopez, Guenther Koehne, Paula Rodriguez Otero, H Miles Prince, Andrea Viqueira, Eric Leip, Umberto Conte, Sharon T Sullivan, Alexander M Lesokhin
Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study. HemaSphere 8 (7) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Juan José Lahuerta, Anastasiia Zherniakova, Jorge M Nuñez-Córdoba, Paula Rodriguez Otero, Qian Shi, Nikhil C Munshi, Brian Durie, Jesús San F Miguel
Impact of treatment effect on MRD and PFS: an aggregate analysis from randomized clinical trials in multiple myeloma. Blood advances (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Enrique María Ocio, Aurore Perrot, Pierre Bories, Jesús San F Miguel, Igor W Blau, Lionel Karlin, Joaquin Martinez-Lopez, Song-Yau Wang, Sara Bringhen, Magda Marcatti, Maria-Victoria Mateos-Manteca, Paula Rodriguez Otero, Stefania Oliva, Axel Nogai, Nadia Le Roux, Liyan Dong, Sandrine Macé, Matthieu Gassiot, Thomas Fitzmaurice, Corina Oprea, Phillipe Moreau
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation. Leukemia (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Marc-Steffen Raab, Elena Zamagni, Salomon Manier, Paula Rodriguez Otero, Schjesvold Fredrik, Annemiek Broijl
Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results. EJHaem 4 (4) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Leire Burgos, Luis Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez Otero, Vladimir Maisnar, Roman Hájek, Frits Van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Juan-José Garcés, María-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan A Flores-Montero, Luzalba Sanoja-Flores, María-José Calasanz, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín-Sánchez, Rafael Martínez-Martinez, Joan Bargay, Anna Sureda, Javier de la Rubia, Miguel-Teodoro T Hernandez Garcia, Paula Rodriguez Otero, Javier de la Cruz, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan José Lahuerta
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Adam David Cohen, Maria-Victoria Mateos-Manteca, Yael C Cohen, Paula Rodriguez Otero, Juan José Lahuerta, Niels W C J van de Donk, Thomas G Martin, Attaya Suvannasankha, Kevin C De Braganca, Christina Corsale, Jordan M Schecter, Helen Varsos, William Deraedt, Liwei Wang, Martin Vogel, Tito Roccia, Xiaoying Xu, Pankaj Mistry, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Jesús San F Miguel
Efficacy and safety of cilta-cel in patients with progressive MM after exposure to other BCMA-targeting agents. Blood (2022)
Paula Rodriguez-Marquez, Maria Eréndira Calleja-Cervantes, Guillermo Serrano, Marta Garrote, Maria L Palacios-Berraquero, Angel Martin-Mallo, Cristina Calviño-Sampedro, Marta Español-Rego, Candela Ceballos, Teresa Lozano, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Rebeca Martinez-Turrillas, Patricia Jauregui, Diego Alignani, María Cruz Viguria, Margarita Redondo, Mariona Pascal, Beatriz Martin-Antonio, Manel Juan, Alvaro Urbano-Ispizua, Paula Rodriguez Otero, Ana Alfonso, Juan José Lahuerta, Juan Jose Lasarte, Susana Inoges, Ascensión López-Díaz de Cerio, Jesús San F Miguel, Carlos Fernández de Larrea, Mikel Hernaez, Juan Roberto Rodriguez-Madoz, Felipe Prosper
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. Science advances 8 (39) (2022)
Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, Joan Bladé, Agne Paner, Maria-Victoria Mateos-Manteca, Michele Cavo, Christopher Maisel, Adrían Alegre, Albert Oriol, Anastasios Raptis, Paula Rodriguez Otero, Amitabha Mazumder, Jacob P Laubach, Omar Nadeem, Anna Sandberg, Marie Orre, Anna Torrång, Nicolaas A Bakker, Paul Gerard Richardson
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. British journal of haematology (2021)